Drug intelligence / Profile preview

cloxazolam

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Cloxazolam is a long-acting benzodiazepine derivative with anxiolytic (anti-anxiety), sedative/hypnotic, muscle relaxant, and antiepileptic properties. It acts as a prodrug and is metabolized in the liver to its active metabolite delorazepam (chlordesmethyldiazepam). The primary mechanism of action involves positive allosteric modulation of the GABA(A) receptor at the benzodiazepine binding site, enhancing the inhibitory effect of GABA in the central nervous system. Cloxazolam is mainly indicated for short-term treatment of anxiety disorders but has also been used for sleep disorders (such as insomnia), premedication before surgery to reduce anxiety and tension, and as adjunctive therapy in epilepsy. It has been marketed primarily in Argentina, Australia, Portugal, Belgium, Switzerland, Luxembourg, Germany, Taiwan and Japan[1][6][7].

Brand names
SepazonOlcadilAktonLubalixBetavel
Other names
cloxazolam
02

Targets

GABA-A receptor α1β2γ2 (GABA_A receptor α1β2γ2 – N-methyllaurotetanine)Gamma-aminobutyric acid type A receptor alpha-2/3/5 subunit-containing complex

Beyond the preview

Go deeper on cloxazolam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cloxazolam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call